← back to search

Ming‐Chi Lu

Tzu Chi University · TW
Area of research
Rheumatology · Psychiatry and Mental health
Research interest
Research interests include Rheumatoid Arthritis Research and Therapies, Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, and Systemic Lupus Erythematosus Research.
h-index
44
citations
10,510
works
329
NIH funding
primary concept
Medicine
email

Recent publications

Decreased expression of circ-CCDC134 mediated by TNF-α in patients with rheumatoid arthritis affects T cell function via targeting protein phosphatase 2A.
2026cited by 0position: contributordoi
Use of the Pay-for-Performance Program in Reducing Sarcopenia Risk: A Nested Case-Control Study Among Patients with Type 2 Diabetes Mellitus.
2026cited by 0position: contributordoi
Association Between the Combined Herbal Medicines and Risk of Dental Diseases in Patients with Rheumatoid Arthritis: Insight from a Nationwide Database.
2026cited by 0position: contributordoi
Influence of Depressive Symptoms on Disease Activity in Patients with Rheumatoid Arthritis: The Mediating Effect of Self-Efficacy.
2026cited by 0position: contributordoi
Mediating Role of Self-Efficacy in the Association Between Fatigue and Depressive Symptoms in Females with Rheumatoid Arthritis.
2025cited by 1position: contributordoi
Global Research on Hemodialysis Nutrition and Patient-Centered Priorities: A Bibliometric Analysis (2006-2025).
2025cited by 0position: contributordoi
Oral Manifestations of Sjögren's Syndrome: Recognition, Management, and Interdisciplinary Care.
2025cited by 0position: contributordoi
Familial Versus Non-Familial Vitiligo: Clinical Features, Anatomical Distribution, and Autoimmune Comorbidity from a Southern Taiwan Hospital.
2025cited by 0position: contributordoi
Mitigating Risk of Premature Ovarian Insufficiency Using Adjunct Chinese Herbal Medicines: A Nested Patient-Control Study in Female Cancer Patients with Chemotherapy.
2025cited by 0position: contributordoi
The Addition of Chinese Herbal Medicines Is Effective as a Prophylactic Treatment Against Dental Diseases for Sjögren's Syndrome Patients: Insight from Real-World Database.
2025cited by 0position: contributordoi
Complementary acupuncture treatment and reduced risk of sudden sensorineural hearing loss in nasopharyngeal carcinoma patients: a retrospective, nested case-control study.
2025cited by 0position: contributordoi
The Combined Treatment of Chinese Herbal Medicines Is Correlated with a Lower Risk of Rheumatoid Arthritis in Patients with Depression: Evidence from a Population-Based Patient-Control Study.
2025cited by 0position: contributordoi
HBV reactivation in HBsAg-/HBcAb+ rheumatoid arthritis patients receiving biologic/targeted synthetic DMARDs.
2024cited by 8position: contributordoi
Targeting PADI2 as a potential therapeutic strategy against metastasis in oral cancer via suppressing EMT-mediated migration and invasion and CCL3/5-induced angiogenesis.
2024cited by 4position: contributordoi
An Exploration of Self-Efficacy and Its Associated Factors among Rheumatoid Arthritis Patients in Taiwan.
2024cited by 3position: contributordoi
Dysregulated Non-Coding RNA Expression in T Cells from Patients with Ankylosing Spondylitis Contributes to Its Immunopathogenesis.
2024cited by 1position: contributordoi
Decreased Risk of Osteoporosis Incident in Subjects Receiving Chinese Herbal Medicine for <i>Sjögren syndrome</i> Treatment: A Retrospective Cohort Study with a Nested Case-Control Analysis.
2024cited by 1position: contributordoi
Integrating Rehabilitation Services into Routine Care of Rheumatoid Arthritis May Reduce the Inflammatory Response: A Hospital-Based Follow-Up Study in Taiwan.
2024cited by 1position: contributordoi
Does the nurse-led case management benefit rheumatoid arthritis patients in reducing distressing symptoms and C-reactive protein: a 2-year follow-up study in Taiwan.
2024cited by 0position: contributordoi
Adjunctive Therapy with Chinese Herbal Medicine Lowers Risk of Hearing Loss in Type 2 Diabetes Patients: Results from a Cohort-Based Case-Control Study.
2024cited by 0position: contributordoi
Donanemab in Early Symptomatic Alzheimer Disease
JAMA 2023cited by 2,415position: middledoi
Increased Expression of Long Noncoding RNA LOC100506314 in T cells from Patients with Nonsegmental Vitiligo and Its Contribution to Vitiligo Pathogenesis.
2023cited by 8position: contributordoi
Rheumatic Diseases: New Progress in Clinical Research and Pathogenesis.
2023cited by 7position: contributordoi
Performance of a New Instrument for the Measurement of Systemic Lupus Erythematosus Disease Activity: The SLE-DAS.
2023cited by 4position: contributordoi
Increased frequency of hospital admissions with active systemic lupus erythematosus disease activity defined by two different disease activity indices: A cohort study.
2023cited by 4position: contributordoi
Integration of Chinese Herbal Medicine into Routine Care Was Related to Lower Risk of Chronic Kidney Disease in Patients with Rheumatoid Arthritis: A Population-Based Nested Case-Control Study in Taiwan.
2023cited by 4position: contributordoi
Increased risk of hospital admissions in patients with active systemic lupus erythematosus (SLE) classified according to two different SLE disease activity indices: a prospective cohort study.
2023cited by 3position: contributordoi
Increased Risk of Developing Systemic Lupus Erythematosus and Rheumatoid Arthritis in Patients with Primary Sjögren's Syndrome-A Secondary Cohort Analysis of Nationwide, Population-Based Claims Data.
2023cited by 3position: contributordoi
Effects of a walking exercise programme on disease activity, sleep quality, and quality of life in systemic lupus erythematosus patients.
2023cited by 3position: contributordoi
Regulatory RNAs in rheumatology: From pathogenesis to potential therapy.
2023cited by 2position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 46 papers (2019–2026)Tzung-Yi Tsai · College of Medicine, National Cheng Kung University16 papers (2021–2026)Malcolm Koo · University of Toronto14 papers (2021–2025)Hanoch Livneh · Portland State University10 papers (2023–2026)P. Murali Doraiswamy · Duke University5 papers (2012–2014)Daniel Skovronsky · Eli Lilly (United States)5 papers (2012–2014)Adam Fleisher · University of California San Diego5 papers (2012–2014)Mark A. Mintun · Resonance Research (United States)5 papers (2012–2014)Marwan N. Sabbagh · Barrow Neurological Institute4 papers (2012–2014)Alan Carpenter · University of California System4 papers (2012–2014)Carl Sadowsky · New York University4 papers (2012–2013)Eric M. Reiman · Alzheimer's Association4 papers (2012–2014)Michael J. Pontecorvo · Eli Lilly (United States)4 papers (2012–2014)Keith A. Johnson · Howard University3 papers (2012–2014)Christopher M. Clark · Allen Institute3 papers (2012–2013)Abhinay D. Joshi · University of California System3 papers (2012–2013)Reisa A. Sperling · Harvard University3 papers (2012–2014)Michael Grundman · University of San Diego3 papers (2012–2014) · 3 papers (2012–2012) · 2 papers (2012–2012)